This page shows results related to Alaway and Asthenopia from the FDA Adverse Event Reporting System (AERS). The adverse event Asthenopia has been reported to the FDA a total of 4 times for Alaway.
Learn More About Alaway Adverse EventsThe Proportional Reporting Ratio (PRR) for Alaway and Asthenopia is 65. The chart below compares this proportional reporting ratio of Asthenopia for drugs used in similar therapies to Alaway. The higher the proportional reporting ratio is, the more likely a drug is associated with Asthenopia.
| Asthenopia | |
| Alaway | 50 |
NOTE: The PRR metric is still in Beta testing by DrugCite and is intended for use by researchers only.
Of those reporting Asthenopia, why were they taking Alaway?
| Seasonal Allergy | 2 |
| Allergy To Animal | 1 |
| Eye Pruritus | 1 |
Which medications reported to the FDA are most commonly associated with Asthenopia?
| Xalatan | 64 |
| Tysabri | 46 |
| Lyrica | 43 |
| Enbrel | 42 |
| Botox Cosmetic | 31 |
| Restasis | 29 |
| Zometa | 29 |
| Risperidone | 23 |
| Latisse | 20 |
| Chantix | 20 |
| Avonex | 19 |
 Show More |
